LiveFuels Team

 

      LiveFuels is a mini-Manhattan Project including the core LiveFuels team, consulting engineers and scientists, and an alliance of DOE labs. 

      NREL, the National Renewable Energy Lab which did the seminal $25 million algae study from 1978 to 1998, signed on in September 2006 to help LiveFuels with the Phase I work.

      Sandia National Labs signed on with LiveFuels in October 2006.  Sandia is presently growing several strains of algae and LiveFuels has the added advantage of access to Sandia’s Combustion Research Facility, which is used by most major car companies to test their engines. 

 

William Spencer PhD:  Chairman of the Board

former CEO, SEMATECH – won back primacy in semiconductors for the U.S.

former CEO, Xerox PARC

former Director, Sandia Labs; previously at Bell Labs

member, National Academy of Engineering

        

David Kingsbury PhD:  Chairman of LiveFuels’ Scientific Advisory Board (SAB)

Presently Chief Science Officer of the Gordon & Betty Moore Foundation

Former CIO, Chiron Corporation

Former NSF advisor

        

Lissa Morgenthaler-Jones:  Founding CEO

        Venture-backed co-founder of Murenove Inc.

#1 fund manager out of 8,000 mutual funds, spring 2000

Finance Committee for Governor Schwarzenegger

Princeton University

 

 Dave Jones:  COO & Business Development

       CFO/Finance & Business Development at public & private companies

Bayhill Therapeutics, Cell Genesys, Kibu, Virage, Murenove

 Raised $35 million at prior biotech company

 Handled $1+ billion liquid asset portfolio at prior biotech company

Cornell & Stanford Universities

 

John Sheehan:  VP, Strategy & Sustainable Development

          DOE National Renewable Energy Lab (NREL) for 16 years

                    Final project manager for the algae-to-biodiesel Aquatic Species Program

                             Lead author on the 300-page report

                    Office of Strategy

          W.R. Grace

          Merck

              

Charity Deluca:  VP, Research Relations

       UCLA, Amgen, Rigel Pharmaceuticals

Biotech analyst for Wall Street firms